Provided by Tiger Trade Technology Pte. Ltd.

Nuvectis Pharma, Inc.

25.89
+2.028.46%
Post-market: 26.000.1100+0.42%19:30 EDT
Volume:276.63K
Turnover:6.95M
Market Cap:843.54M
PE:-19.85
High:25.94
Open:23.90
Low:23.85
Close:23.87
52wk High:29.28
52wk Low:5.55
Shares:32.58M
Float Shares:21.23M
Volume Ratio:1.12
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3045
EPS(LYR):-1.3236
ROE:-214.58%
ROA:-73.07%
PB:92.88
PE(LYR):-19.56

Loading ...

Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2022

Major Issues Report

8-K - Current report
Aug 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 15, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Major Issues Report

8-K - Current report
Jul 29, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 28, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 02, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 02, 2022

Correspondence

CORRESP [Cover] - Correspondence